It was shown to downregulate IFNγ-induced MHC-I expression in non-small cell lung cancer cell lines (49), and CD80/CD86 in dendritic cells stimulated with lipopolysaccharide, thereby reducing T-cell stimulatory capacity (36). This evidence concerns the gene CD86 and non-small cell lung carcinoma.